Many thanks to all participants, collaborators, and to @incliva_iis for their continued support.

🚩Improving targeted detection in at-risk populations could help prevent severe complications in the future.

Screening should be particularly considered in:
• People originating from endemic areas
• Patients with immunosuppression, or before starting immunosuppressive therapy

During 2015–2024, we observed an increase in the annual number of diagnoses.

This rise likely reflects:
🔬 Substantial increase in diagnostic testing and screening
👩‍⚕️ Greater clinical awareness
🌍 Growth in imported cases
📍 Autochthonous cases remained stable over time

👁️‍🗨️In our study we included 301 patients diagnosed between 2015 and 2024:
• Median age: 53 years
• 45% women
• 59% autochthonous cases
• 41% migrants, mainly from Latin America

🔎56% were symptomatic at diagnosis. Eosinophilia was present in 48% of cases.

📢 New study on strongyloidiasis in the Valencian Community.
Although considered a neglected tropical disease, it is also detected in temperate regions such as Spain, where it likely remains underdiagnosed.

@seimc.bsky.social @incliva_iis @TropicalmedMDPI GVAclinic

www.mdpi.com/2414-6366/11...

Spain is committed to evidence-based, differentiated, and person-centred prevention.
A necessary step forward to close gaps in access and adherence among the most vulnerable populations.
💪🏼🇪🇸

España, primer país de la Unión Europea en financiar la PrEP inyectable frente al VIH El Sistema Nacional de Salud incorpora Apretude (cabotegravir de acción prolongada) como prestación farmacéutica financiada en situaciones en las que la PrEP oral no es alternativa. La medida sitúa a ...

As a professional dedicated to HIV prevention, I am particularly proud today.
The public funding of long-acting cabotegravir as #PrEP represents a decisive step forward in strengthening the response to the HIV epidemic in Spain.
www.sanidad.gob.es/en/gabinete/...

INCLIVA obtiene una beca para acercar las medidas preventivas frente al VIH y los servicios de salud sexual a las personas más vulnerables El proyecto ‘The exPrEPsso Study: Ensuring Equitable Access and Retention in PrEP care in Spain’, arrancará en enero de 2026 y tendrá una duración de dos años Se evaluará el acceso al sistema sanita...

Very proud of this team! 💪🏼❤️‍🔥
www.incliva.es/incliva-obti...

La Comisión Europea autoriza Yeytuo® Lenacapavir Gilead Sciences anuncia que la Comisión Europea CE ha concedido la autorización de comercialización para Yeytuo® lenacapavir un inhibidor de la cápside

🙌🏼More flexible PrEP regimens may improve access and adherence, particularly crucial for reaching underserved or hard-to-reach populations in HIV prevention efforts.

www.immedicohospitalario.es/noticia/5250...

🔥News: Expansion of long-acting injectable PrEP options in Europe

The European Commission has authorized Yeytuo® (lenacapavir), a twice-yearly injectable PrEP, for adults and adolescents (≥35 kg) at increased HIV‑1 risk across the EU‑27, Norway, Iceland, and Liechtenstein 👇🏼

🔴 Ya disponible el programa científico del Congreso Nacional de GeSIDA de 2025.

🔎 Descubre nuestros ponentes inaugurales, los contenidos de las sesiones plenarias y de las mesas clínicas y de ciencia básica.

➡️ www.congresogesida.es

#GeSIDA25

💬 Is a rollout justified with 30% efficacy?
In a context of rising resistance and no alternative vaccine candidates, this might be a reasonable public health decision.

📍The NHS will pilot this strategy in MSM with recent STI or multiple sexual partners.

#Gonorrhea #Vaccines #AMR #STIs #MenB

How the Meningitis Vaccine Might Protect Against Gonorrhea This Medical News article discusses the discovery of antigens that may explain reductions in gonococcal infections following meningococcal B vaccination.

📢 JAMA (2025)

The meningococcal B vaccine (4CMenB) shows ~30% protection against gonorrhea.

🔬 Recent data identify 2 cross-reactive antigens: PorB and LOS.
🧪 Not classically immunogenic, yet may be key for future vaccines.

jamanetwork.com/journals/jam...

Following FDA approval of lenacapavir for HIV PrEP, the IAS-USA panel has released an updated brief of its 2024 recommendations.
🔹 LEN for all populations
🔹 TAF/FTC for cisgender women

🔥These updates mark an important shift in the PrEP landscape.

#PrEP #HIV #Lenacapavir #TAF

Preexposure Prophylaxis for HIV To the Editor Following the US Food and Drug Administration approval of lenacapavir for HIV preexposure prophylaxis (PrEP) on June 18, 2025, as well as new data on the use of tenofovir alafenamide/emt...

📢New in JAMA!

jamanetwork.com/journals/jam...

📢 BASHH has today published national clinical guidelines on the use of doxyPEP.

This makes the UK one of the first countries globally to offer formal clinical direction on this STI prevention strategy.

🔗 Read our full statement & access the guidelines: bit.ly/4475DDK

Thanks to all patients, collaborating centers, and investigators involved in this effort.

Full text here 👇🏼👇🏼
sciencedirect.com/science/articl…

@gesida-seimc.bsky.social @GEHEP @seimc.bsky.social @CIBERINFEC

These results suggest a slower fibrosis regression in PLWH, potentially translating into a persistent risk of liver-related complications, even after HCV eradication.

#HCV #HIV #HepatitisC

After propensity score matching and competing risks modeling (death as competing event), HIV co-infection was independently associated with reduced probability of LS normalization:

37% in HCV vs. 32% in HIV/HCV (p = 0.003)

Adjusted sub-HR = 0.76 (95% CI: 0.56–0.97).

🔥Just published in eClinicalMedicine!

We analyzed the impact of HIV on liver stiffness (LS) dynamics after HCV cure in a large prospective cohort of 1,138 patients with F3/F4.

Key finding: PLWH had a significantly lower probability of LS normalization (≤7.2 kPa), despite SVR.

XV Jornadas de Enf. Emergentes
acreditadas por SNS

👉2-3 junio Auditorio @combarcelona.bsky.social
Formato híbrido
Programa definitivo e inscripciones:
uitb.cat/event/xv-jorna…

@salutpublicabcn.bsky.social #ServeisClinics #lokimica #Vircell @abbottnews.bsky.social

#EnfEmerg

Thank you very much to all the participants🙏🏼

@GEHEP @Evirologia @ofidjournal.bsky.social
#HIVSky #HCVSky

Curious about long-term outcomes after DAA therapy?
This one's for you!
Share & discuss 🔁 🧠

🇪🇦 GEHEP-011

Main findings:
• ⏳ Follow-up: median 6 years
• 12%liver events (5% HCC)
• 📊 Diagnostic performance: LS had better accuracy (AUROC 0.83 vs 0.80)
• ✅ LS <14 kPa identified 52% as low risk, missing only 3 events (1.9%)
• ✅ FAST ≤0.35 identified 59% as low risk, but missed 6 events (3.3%)

FibroScan-AST Score vs Liver Stiffness for the Prediction of Liver Events After HCV Cure AbstractBackground. Liver stiffness (LS) predicts liver complication occurrence in patients with hepatitis C virus (HCV) infection after sustained virologi

📢New publication out!

🧐Can the FAST score better predict liver events after HCV cure?
We compared FAST score vs liver stiffness (LS) in 300 patients (71%PLWH)

📨Key takeaway: FAST helps, but LS alone still performs better at predicting post-SVR complications.

👇🏼👇🏼 Read more: doi.org/10.1093/ofid...

"We condemn the censoring of science!". Powerful opening words from Diane Havlir for #croi2025

"Young researchers, we have your back. Community, we are with you"

Hell yes!!!

Are you going to #CROI2025 in San Francisco?

We hope to see you at the rally to protect critical HIV research + programming: p2a.co/YS8dsxA

📢 ¡Inscripciones abiertas!

Ya puedes registrarte en la Reunión “Cuidados diversos para necesidades diversas”, 🗓️ martes 29 de abril en la Facultad de Educación UNED

Inscripción aquí 🔗 [https://www.seisida.net/reunion2025/] #CuidadosDiversos #Educación @uneduniv.bsky.social
#Seisida2025

2024 Anal Cancer Screening Guidelines: Analysis of Clinical Performance and HRA Utilization in a large Cohort of Persons with HIV

« … all triage and co-testing strategies outperformed cytology alone. »

#IDsky #HIVsky

academic.oup.com/cid/advance-...

Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends This study assesses the association of citywide doxycycline postexposure prophylaxis guideline release with reported chlamydia, gonorrhea, and early syphilis cases in men who have sex with men and in ...

Decrease In California’s STIs Followed Early Real-World Adoption Of DoxyPEP

#IDSky
#STI
#PublicHealth

jamanetwork.com/journals/jam...

Men who have sex with men in Europe still vulnerable to hepatitis A and B, highlighting need for public health action and support Research analysing European survey data from 113,884 men who have sex with men (MSM) and published in Eurosurveillance indicates that while most MSM have a basic understanding of viral hepatitis, only...

Research analysing #European survey data from 113,884 men who have sex with men (MSM) indicates that

🔹 most MSM have a basic understanding of #viral #hepatitis

🔸 only 44% report having been vaccinated against both hepatitis A & B

#publichealth #sexualhealth 😷💉⚕️
www.eurekalert.org/news-release...